Lead Exposure Intervention Program

Lead Exposure Intervention Program

The goal of this clinical trial is to learn if BLL (blood lead level) screening and "healthy home" lead prevention program created in the US is adaptable to a Sub-Saharan African context. It will also work to address child lead exposure in Nairobi, Kenya. The main questions it aims to answer is:

• Can materials and protocols developed for a US audience be effective in a Sub-Saharan African one?
• Is there a difference in learning and action between groups that receive different degrees of intervention?

Researchers will compare the outcomes of a group that received lead risk reduction information only in the clinical setting to a group that also received a home visit and tailored risk reduction messages.

Participants will:

• Have their child's blood lead levels measured at several timepoints
• Take part in a questionnaire about lead risk
• Receive lead risk reduction messaging either only in the clinic setting or also in their homes
• Have their knowledge and risk reduction behaviors measured

Inclusion Criteria:

• Caregivers with children ages 12-72 months attending routine care/vaccination visit at Nairobi clinical site.

Exclusion Criteria: Children outside of age range, caregivers younger than 18; plan to leave study catchment within 9 months.

-